drugset / Trial / NCT04935112
A Study to Explore the Effect of Acid-reducing Agents
Non-randomizedCrossoverOpen-labelOther
Summary
A Phase 1 Study of the Effect of Acid-reducing Agents on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects. The study is a single-center, open-label, 2-period, 2-treatment, fixed-sequence crossover, parallel-group study.
Timeline
- Start
- 2021-07-07
- Primary completion
- 2021-08-12
- Completion
- 2022-07-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famotidine | Other / unclassified | 40 mg | Oral |
| Subject | Pantoprazole | Other / unclassified | 40 mg | Oral |
| Subject | Sitravatinib | Small molecule | 100 mg | Oral |
Indications
No indication recorded.